Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP750642.RAfotPglhaX3cMRO_MGkLYM9L6KYivt-N0wdDTM7IXbbg130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP750642.RAfotPglhaX3cMRO_MGkLYM9L6KYivt-N0wdDTM7IXbbg130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP750642.RAfotPglhaX3cMRO_MGkLYM9L6KYivt-N0wdDTM7IXbbg130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP750642.RAfotPglhaX3cMRO_MGkLYM9L6KYivt-N0wdDTM7IXbbg130_provenance.
- NP750642.RAfotPglhaX3cMRO_MGkLYM9L6KYivt-N0wdDTM7IXbbg130_assertion description "[Cenersen, an oligonucleotide targeting TP53, has been shown to abrogate the activity of TP53 gain-of-function mutants and to increase sensitivity of lymphoma cells to cytotoxic chemotherapy in vitro.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP750642.RAfotPglhaX3cMRO_MGkLYM9L6KYivt-N0wdDTM7IXbbg130_provenance.
- NP750642.RAfotPglhaX3cMRO_MGkLYM9L6KYivt-N0wdDTM7IXbbg130_assertion evidence source_evidence_literature NP750642.RAfotPglhaX3cMRO_MGkLYM9L6KYivt-N0wdDTM7IXbbg130_provenance.
- NP750642.RAfotPglhaX3cMRO_MGkLYM9L6KYivt-N0wdDTM7IXbbg130_assertion SIO_000772 21827374 NP750642.RAfotPglhaX3cMRO_MGkLYM9L6KYivt-N0wdDTM7IXbbg130_provenance.
- NP750642.RAfotPglhaX3cMRO_MGkLYM9L6KYivt-N0wdDTM7IXbbg130_assertion wasDerivedFrom befree-20150227 NP750642.RAfotPglhaX3cMRO_MGkLYM9L6KYivt-N0wdDTM7IXbbg130_provenance.
- NP750642.RAfotPglhaX3cMRO_MGkLYM9L6KYivt-N0wdDTM7IXbbg130_assertion wasGeneratedBy ECO_0000203 NP750642.RAfotPglhaX3cMRO_MGkLYM9L6KYivt-N0wdDTM7IXbbg130_provenance.
- befree-20150227 importedOn "2015-02-27" NP750642.RAfotPglhaX3cMRO_MGkLYM9L6KYivt-N0wdDTM7IXbbg130_provenance.